Frontiers in Immunology (Jul 2022)

TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells

  • Helen Carrasco Hope,
  • Helen Carrasco Hope,
  • Gabriella Pickersgill,
  • Pierpaolo Ginefra,
  • Nicola Vannini,
  • Graham P. Cook,
  • Robert J. Salmond

DOI
https://doi.org/10.3389/fimmu.2022.913184
Journal volume & issue
Vol. 13

Abstract

Read online

T cell activation is dependent upon the integration of antigenic, co-stimulatory and cytokine-derived signals and the availability and acquisition of nutrients from the environment. Furthermore, T cell activation is accompanied by reprogramming of cellular metabolism to provide the energy and building blocks for proliferation, differentiation and effector function. Transforming growth factor β (TGFβ) has pleiotropic effects on T cell populations, having both an essential role in the maintenance of immune tolerance but also context-dependent pro-inflammatory functions. We set out to define the mechanisms underpinning the suppressive effects of TGFβ on mouse CD8+ T cell activation. RNA-sequencing analysis of TCR-stimulated T cells determined that Myc-regulated genes were highly enriched within gene sets downregulated by TGFβ. Functional analysis demonstrated that TGFβ impeded TCR-induced upregulation of amino acid transporter expression, amino acid uptake and protein synthesis. Furthermore, TCR-induced upregulation of Myc-dependent glycolytic metabolism was substantially inhibited by TGFβ treatment with minimal effects on mitochondrial respiration. Thus, our data suggest that inhibition of Myc-dependent metabolic reprogramming represents a major mechanism underpinning the suppressive effects of TGFβ on CD8+ T cell activation.

Keywords